Walsh & Hoyt: Antimetabolites

Update Item Information
Identifier wh_ch37_p1760
Title Walsh & Hoyt: Antimetabolites
Creator Mark L. Moster, MD; Rod Foroozan, MD
Affiliation (MLM) Thomas Jefferson University; (RF) Baylor College of Medicine
Subject Neoplasms; Neoplasms, Therapy; Chemotherapy, Adverse Effects; Radiotherapy, Adverse Effects; Bone Marrow Transplantation, Adverse Effects; Antimetabolites; Complications of Cancers; Neuro-ophthalmic Complications of Chemotherapy
Description These drugs interfere with the production of nucleic acids by three mechanisms. Some inhibit production of the deoxyribonucleoside triphosphates that are the immediate precursors for deoxyribonucleic acid (DNA) synthesis, thus inhibiting the replication process. Extended periods of inhibition of this process are usually cytotoxic. Others are substituted for purines or pyrimidines in the anabolic nucleotide pathways. Finally, some antimetabolites produce apoptosis programmed cell death in susceptible cells. In some cases, more than one mechanism is responsible for the effects of the drug. Methotrexate (MTX). 5-Fluorouracil (5-FU). Gemcitabine. Purine analogs. Fludarabine. Cladribine. Pentostatin. Pyrimidine analogs. Bromodeoxyuridine (BUdR). Hydroxyurea.
Date 2005
Language eng
Format application/pdf
Type Text
Source Walsh and Hoyt's Clinical Neuro-Ophthalmology, 6th Edition
Relation is Part of Walsh and Hoyt's Clinical Neuro-Ophthalmology Walsh and Hoyt's Clinical Neuro-Ophthalmology
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Wolters Kluwer Health, Philadelphia
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah, 10 N 1900 E SLC, UT 84112-5890
Rights Management Copyright 2005. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6p306kv
Setname ehsl_novel_whts
ID 186141
Reference URL https://collections.lib.utah.edu/ark:/87278/s6p306kv
Back to Search Results